Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study

Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study

Tocilizumab (TCZ) has demonstrated potential efficacy in managing large-vessel (LV) vasculitis such as giant-cell arteritis (GCA) and Takayasu arteritis (TAK). Despite the shared characteristics between the LV-GCA phenotype and TAK, there are differences between both entities that may affect therape...

Full description

Saved in:
Bibliographic Details
Main Authors: Carmen Lasa-Teja, Javier Loricera, Diana Prieto-Peña, Fernando López-Gutiérrez, Pilar Bernabéu, María Mercedes Freire-González, Beatriz González-Alvarez, Roser Solans-Laqué, Mauricio Mínguez, Iván Ferraz-Amaro, Santos Castañeda, Ricardo Blanco, on behalf of the Tocilizumab in Large-Vessel Vasculitis Spanish Collaborative Group
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Sci
Subjects:
tocilizumab
Takayasu’s arteritis
giant-cell arteritis
large-vessel vasculitis
Online Access:https://www.mdpi.com/2413-4155/7/1/12
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2413-4155/7/1/12

Similar Items